Successful reversal of resistent hypodynamic septic shock with levosimendan
2005; Wiley; Volume: 49; Issue: 1 Linguagem: Inglês
10.1111/j.1399-6576.2005.00541.x
ISSN1399-6576
AutoresMartin Matějovič, Aleš Kroužecký, Jaroslav Raděj, Ivan Novák,
Tópico(s)Antibiotics Pharmacokinetics and Efficacy
ResumoActa Anaesthesiologica ScandinavicaVolume 49, Issue 1 p. 127-127 Successful reversal of resistent hypodynamic septic shock with levosimendan M. Matejovic, Corresponding Author M. Matejovic * Martin Matejovic, MD, PhD ICU 1st Medical Department Charles University Medical School and Teaching Hospital Alej svobody 80 304 60 Plzen Czech Republic e-mail: [email protected]Search for more papers by this authorA. Krouzecky, A. KrouzeckySearch for more papers by this authorJ. Radej, J. RadejSearch for more papers by this authorI. Novak, I. NovakSearch for more papers by this author M. Matejovic, Corresponding Author M. Matejovic * Martin Matejovic, MD, PhD ICU 1st Medical Department Charles University Medical School and Teaching Hospital Alej svobody 80 304 60 Plzen Czech Republic e-mail: [email protected]Search for more papers by this authorA. Krouzecky, A. KrouzeckySearch for more papers by this authorJ. Radej, J. RadejSearch for more papers by this authorI. Novak, I. NovakSearch for more papers by this author First published: 26 January 2005 https://doi.org/10.1111/j.1399-6576.2005.00541.xCitations: 32Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Follath F, Cleland JG, Just H et al. Efficacy of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196–202.DOI: 10.1016/S0140-6736(02)09455-2 2 Oldner A, Konrad D, Weitzberg E et al. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock. Crit Care Med 2001; 29: 2185–93.DOI: 10.1097/00003246-200111000-00022 Citing Literature Volume49, Issue1January 2005Pages 127-127 ReferencesRelatedInformation
Referência(s)